<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD>
<META http-equiv=Content-Type content="text/html; charset=iso-8859-1">
<META content="MSHTML 6.00.6000.16587" name=GENERATOR>
<STYLE></STYLE>
</HEAD>
<body bgcolor=#FFFFFF text=#000000>
<img src="http://www.qualsensors.com/images/qualsec/logo.png"><br>
<table border=0 width`0>
<td>
<b><Font face="arial" size="3">QUALSEC ( QLSC.PK )<br>
<font face="arial" size=2>
Last Trade June 14: 0.37<br></b>
<br>
QualSec announces the development of the NanoNose, the next generation in electronic nose threat
detection devices. Utilizing its patent pending ROder technology, QualSec is creating a hand held
electronic device that can detect explosives, communicable diseases and hazardous materials in real time
with instant read out of the threat and its level of concentration in ambient air.
<P>
About QualSec, INC. (QLSC): www.qualsensors.com
<P>
QualSec Inc. (QLSC) is the developer of the Nano-Nose, the next generation of electronic olfactory
sensory technology. We develop cutting-edge proprietary detection systems which meets the discrimination,
sensitivity, portability, and other unmet needs in the homeland security market as well as applications
in other high volume markets including the health care, environmental, petrochemical, and food industry.
QualSec's technology also has near-term applications for protection against biological warefare agents
and the spread of terrorist initiated epidemics.
<p>
QualSec was formed in the Fall of 2006 by Joel Hand and Arden Kelton, Ph.D. Mr. Hand and Dr. Kelton have
been associated in various projects for more than 20 years.
<P>
QualSec.s operations are led by Dr. Arden A. Kelton. Dr. Kelton received his doctorate in Medical Physics
from U.C.L.A. in 1969 and has been a biotechnology entrepreneur for more than 25 years. During 2002 and
2003, Dr. Kelton served as CEO for Osprey Data Systems Corp., a company that was developing an electronic
nose based on thin film resonance technology. Due to lack of funding and the death of a key manager,
Osprey eventually abandoned its electronic nose project. During his time with Osprey, Dr. Kelton gained
knowledge of the potential business opportunities for an advanced electronic nose as well as the several
problems inherent in the many different technical approaches being pursued by several academic
institutions, government agencies, and industries.
<P>
During 2005 and 2006, Dr. Kelton developed a general concept that could avoid many of the problems
inherent in other approaches. The concept is based on his earlier work with centrifugal analyzers. This
new approach, dubbed ROder technology, became the basis for the formation of QualSec Inc. by Joel Hand
and Dr. Kelton in November 2006. In order to actualize the approach and solve remaining technical
obstacles, QualSec subcontracted development to NAC, a technology development company owned and operated
by Dr. Kevin Pegg. Dr. Pegg had previously worked with Dr. Kelton on other hi-tech developments by
entrepreneurial biotech companies. He currently teaches biotechnology classes at the Advanced Technology
Center in Jacksonville, part of the University of Florida, and has successfully accomplished numerous
technology projects under contracts to federal and state agencies as well as major industries. In
addition to his doctorate in molecular genetics, and postdoctoral training in chemical engineering, Dr.
Pegg is skilled in optics, electronics, and information technology. He is also a licensed patent agent.
<p>
QualSec is at the forefront of the olfactory development race. With our robust architecture and quality
assurances, the devices that we develop surpass any other technology of their kind.
<P>
The engine behind our success is our internally developed, proprietary ROder Technology which is
implemented into powerful, yet compact air samplers. Devices that operate on ROder Technology meet the
discriminatory needs of sensitivity and portability while providing real-time results with impeccable
accuracy.
<p>
A device that utilizes the ROder Technology will operate with four discrete functions:
<P>
<img src="http://www.qualsensors.com/images/qualsec/roder.png">
<P>
Air circulation over the testing substrate
<P>
Interaction of the testing compound with airborne chemicals
<p>
Analysis of the test results
<p>
Communication of the results to the user
<P>
<img src="http://www.qualsensors.com/images/qualsec/steps.png">
<P>
QualSec's ROder enabled devices have applications in many high volume markets including; homeland
defense, law enforcement, health care, environmental, agricultural, petrochemical, and food industries.
<P>
<br><BR>
<font face="arial" size=1>
Information within this report contains forward looking statements
within the meaning of Section 27A of the Securities Act of 1933 and
Section 21B of the SEC Act of 1934. Past performance
is never indicative of future results
We have received a 25,000.00 cash payment for out advertising services.
Third parties own stock and will sell those shares
without notice to you, this could cause the price to go down.
This report shall not be construed as any kind
of investment advice or solicitation.
</td></table>
</font>